Home McKesson Corp. Rating Increased to Overweight at Morgan Stanley
 

Keywords :   


McKesson Corp. Rating Increased to Overweight at Morgan Stanley

2013-10-26 15:45:19| Biotech - Topix.net

The firm currently has a $177.00 price objective on the stock. Morgan Stanley's price target indicates a potential upside of 14.20% from the company's current price.

Tags: rating increased corp morgan

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.06Atlantic Tropical Weather Outlook
25.06Eastern North Pacific Tropical Weather Outlook
25.06Will there be more air travel chaos this summer?
25.06Bankruptcy trustee plans to shut down Alex Jones' Infowars
25.06Eastern North Pacific Tropical Weather Outlook
25.06Atlantic Tropical Weather Outlook
25.06The screen tech that can do almost anything
25.06Criminal charges recommended against Boeing
More »